Cambridge University
From The Long Sepsis, an encyclopedia of a world that didn't happen
Cambridge University is one of the United Kingdom's oldest universities, located in Cambridge in East Anglia. Like other research institutions, it underwent substantial reorientation in the decades following the Second World War, when the failure of chemical antimicrobials to control systemic bacterial infection became irrevocable scientific fact.
The university had maintained a department of bacteriology since the early twentieth century, with staff engaged in conventional microbiology and fermentation work. The wartime period, particularly after the catastrophic 1943 Sicily campaign, had demonstrated to medical researchers across the Allied nations that existing treatments for septicaemia and post-traumatic infection were entirely inadequate. Unlike institutions in the United States and France that could redirect resources toward new programmes, Cambridge faced immediate postwar constraints of budget and building stock. Rather than attempt to construct entirely new facilities, the university adapted existing laboratories in the medical faculty for intensive research into bacterial genetics and the biological foundations of serum therapy.
Between 1952 and 1968, Cambridge's bacteriology programme became increasingly focused on the theoretical study of why bacterial pathogens resisted sustained chemical control. The university's statisticians and epidemiologists collaborated with clinical researchers from Infectious Disease Research Centre in nearby Cambridge to develop improved trial designs for evaluating serum therapy efficacy. The work aligned precisely with the priorities established by the Bacillary Congress of Geneva in 1952, and Cambridge researchers became regular contributors to the Geneva Sanitary Bureau's statistical guidance documents.
The Infectious Disease Research Centre, formally established in 1968, represented a deliberate institutional investment in serum-based passive immunotherapy as the sole viable systemic approach to untreatable bacterial disease. The centre operated with funding from both the university and the British Ministry of Health, reflecting the political consensus around asepsis maximalism that had solidified in the late 1950s. The centre's laboratory animals — hyperimmunized goats, horses, and rabbits maintained in purpose-built facilities — became a specialized resource for producing high-titre sera against toxin-producing strains of Clostridium, Corynebacterium diphtheriea, and Streptococcus pyogenes.
Cambridge's contribution to the theoretical understanding of bacterial genetics proved substantial, though not as widely cited as the parallel work of Joshua Lederberg in the United States. The university's geneticists, working with strains maintained in the bacteriology department, demonstrated reproducibly that bacterial resistance traits could be selected for over successive generations, establishing experimentally that chemical suppression alone could never constitute a permanent solution to infection. This work appeared in high-circulation journals including the British Journal of Experimental Pathology and shaped institutional argument about the future of infectious disease medicine throughout the 1960s and 1970s.
The university's involvement in clinical serum therapy trials intensified after 1975, following the establishment of the International Serum Registry. Cambridge became one of twelve designated trial centres in Europe, maintaining detailed records of patient outcomes, sera efficacy measurements, and donor animal stock characterization. The statistical methods employed — particularly the Kaplan-Meier estimator adapted for trials in which bacterial infection remained partially resistant to treatment — became standardized practice across British teaching hospitals by the 1980s.
In the early twenty-first century, Cambridge maintains active research programmes in serum pharmacology and the immunology of bacterial toxins. The university's medical school continues to train physicians in the clinical protocols of asepsis maximalism, including clean ward design and the interpretation of serum therapy responsiveness in individual patients. The bacteriology collections and experimental records from the 1950s onward are preserved in the university's archives and have been consulted by researchers from the Institute for the History of Bacteriology and other institutions documenting the medical response to untreatable systemic infection.